AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Discover the key moments for choosing short term investments. Timing your investments can significantly impact your returns.
26,180 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Two cloud software giants sit side by side in the growth-at-any-cost debate. This article breaks down whether should ...
Amazon faces a cash-heavy growth cycle as cloud demand and custom chips drive revenue. The market clamps down on near...
After the first quarter, the sharkninja 2026 earnings call reveals a company balancing strong demand with cost pressu...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
A prominent fiduciary family office recently exited a sizable international value ETF position, prompting questions a...
In June, the stock market faces a delicate balance between AI excitement and real-world demand. Broadcom’s results sh...
AI chip headlines are steering market moves this June. From Google’s foundry ambitions to Intel's refreshed strategy,...
Intel reveals a slate of high-impact partnerships and capacity expansions that could redefine its role in AI and clou...
As AI infrastructure names retreat from spring highs, June market conditions and resilient AI demand are prompting in...
Broadcom’s latest price move came on the back of a price-target cut and AI optimism colliding with caution. This guid...
The memory market has been on a wild ride. After sharp gains earlier this year, Micron and SanDisk pulled back, promp...